Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Alzheimer's Disease

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 23 articles: HTML format

Single Articles

October 2024
1. LOPERA F, Arboleda-Velasquez JF
   APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease. Reply.
   N Engl J Med. 2024;391:1661.
   PubMed    
   
   
   
2. COCHRAN JN, Greicius MD, Goate AM
   APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease.
   N Engl J Med. 2024;391:1660-1661.
   PubMed    
   
   
   June 2024
3. CHIN NA, Erickson CM
   Alzheimer's Disease, Biomarkers, and mAbs - What Does Primary Care Need?
   N Engl J Med. 2024;390:2229-2231.
   PubMed    
   
   
   
4. STEFANSSON H, Walters GB, Sveinbjornsson G, Tragante V, et al
   Homozygosity for R47H in TREM2 and the Risk of Alzheimer's Disease.
   N Engl J Med. 2024;390:2217-2219.
   PubMed    
   
   
   
5. HARDY J
   Protection against Alzheimer's Disease with APOE Christchurch Variant - How?
   N Engl J Med. 2024;390:2212-2213.
   PubMed    
   
   
   
6. QUIROZ YT, Aguillon D, Aguirre-Acevedo DC, Vasquez D, et al
   APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease.
   N Engl J Med. 2024;390:2156-2164.
   PubMed     Abstract available
   
   
   March 2024
7. CHIN NA, Dinsmore D, Gonzales T, Groves B, et al
   Alzheimer's Disease - Managing Stages of Dementia.
   N Engl J Med. 2024;390:e29.
   PubMed    
   
   
   
8. CHIN NA, Dinsmore D, Gonzales T, Groves B, et al
   Alzheimer's Disease - Anti-Amyloid Medications, Early Detection, and Screening.
   N Engl J Med. 2024;390:e22.
   PubMed    
   
   
   February 2024
9. BATEMAN RJ, Smith J, Doody RS
   Gantenerumab in Early Alzheimer's Disease. Reply.
   N Engl J Med. 2024;390:867.
   PubMed    
   
   
   
10. WANG Z, Zhao B, Jia J
    Gantenerumab in Early Alzheimer's Disease.
    N Engl J Med. 2024;390:866.
    PubMed    
    
    
    
11. MAYEUX R
    Alzheimer's Disease Biomarkers - Timing Is Everything.
    N Engl J Med. 2024;390:761-763.
    PubMed    
    
    
    
12. JIA J, Ning Y, Chen M, Wang S, et al
    Biomarker Changes during 20 Years Preceding Alzheimer's Disease.
    N Engl J Med. 2024;390:712-722.
    PubMed     Abstract available
    
    
    January 2024
13. REZAI AR, D'Haese PF, Finomore V, Carpenter J, et al
    Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease.
    N Engl J Med. 2024;390:55-62.
    PubMed     Abstract available
    
    
    November 2023
14. 
    Alzheimer's Update, Part 2: ITT Episode 21.
    N Engl J Med. 2023;389:e43.
    PubMed    
    
    
    
15. SCHNEIDER LS
    What the Gantenerumab Trials Teach Us about Alzheimer's Treatment.
    N Engl J Med. 2023;389:1918-1920.
    PubMed    
    
    
    
16. BATEMAN RJ, Smith J, Donohue MC, Delmar P, et al
    Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
    N Engl J Med. 2023;389:1862-1876.
    PubMed     Abstract available
    
    
    
17. 
    Alzheimer's Update, Part 1: ITT Episode 20.
    N Engl J Med. 2023;389:e33.
    PubMed    
    
    
    July 2023
18. SPERLING RA, Donohue MC, Raman R, Rafii MS, et al
    Trial of Solanezumab in Preclinical Alzheimer's Disease.
    N Engl J Med. 2023 Jul 17. doi: 10.1056/NEJMoa2305032.
    PubMed     Abstract available
    
    
    April 2023
19. VAN DYCK CH, Sabbagh M, Cohen S
    Lecanemab in Early Alzheimer's Disease. Reply.
    N Engl J Med. 2023;388:1631-1632.
    PubMed    
    
    
    
20. BRENMAN JE
    Lecanemab in Early Alzheimer's Disease.
    N Engl J Med. 2023;388:1631.
    PubMed    
    
    
    
21. POMARA N, Imbimbo BP
    Lecanemab in Early Alzheimer's Disease.
    N Engl J Med. 2023;388:1630-1631.
    PubMed    
    
    
    
22. VALENZUELA MJ, Pascual-Leone A
    Lecanemab in Early Alzheimer's Disease.
    N Engl J Med. 2023;388:1630.
    PubMed    
    
    
    
23. ZENG BS, Tseng PT, Liang CS
    Lecanemab in Early Alzheimer's Disease.
    N Engl J Med. 2023;388:1630.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.